Efficacy of platelet rich plasma (PRP) in treatment of tennis elbow: A prospective study
European Journal of Molecular & Clinical Medicine,
2023, Volume 10, Issue 3, Pages 124-131
AbstractTennis Elbow [Lateral Epicondylitis] is one of the most commonly encountered musculoskeletal entities in OPD with incidence of 4-7 per 1000 with a peak at 35-40 years. Overuse activity may be the cause of disease.
Conservative Management includes activity modification, RICE Regime [Rest, Ice Compression, Elevation], NSAIDs, Corticosteroid Injection. Corticosteroid Injection works by suppressing inflammatory process. Platelet Rich Plasma [PRP] has been promoted as biologic autologous blood derived product. It works by releasing high concentrations of platelet derived growth factors [PDGF]. These growth factors stimulate stem cell recruitment, increases local vascularity and directly stimulates production of collagen by tendon sheath fibroblast thus enhancing tendon healing
- Article View: 57
- PDF Download: 90